Top Warren Buffett Stocks To Own Right Now

Warren Buffett’s  Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) needs little introduction, but if you’re looking for the next Berkshire, you might be surprised to find it in China. Tech giant Tencent (OTC:TCEHY) has an impressive portfolio of companies that’s been valued at as much as $250 billion, and it also owns the super-app WeChat, whose competitive advantages are manifest.

In this segment of Backstage Pass, recorded on Aug. 23, Fool contributor Jeremy Bowman explains some of the surprising similarities between the two companies.

Jeremy Bowman: So Tencent is the parent of WeChat. That’s most of their business. WeChat is basically a super-app that I think does pretty much all the things we might use in apps like Facebook, or YouTube, or Uber for here. That’s all rolled into one app with WeChat. It’s really a huge business for Tencent. It pairs with other companies. Tencent, you have to think of it in two ways. It’s first the WeChat, and then secondly, they have a really prolific investment portfolio. I think you can almost compare them to something like Berkshire Hathaway in some ways.

Top Warren Buffett Stocks To Own Right Now: Laboratory Corporation of America Holdings(LH)

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company?s specialty tests and related services comprise viral load measurements, genotyping and phenotyping, and host genetic factors for managing and treating HIV infections; cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests for diagnostic genetics; oncology tests for diagnosing and monitoring certain cancers and treatments; clinical trials testing for pharmaceutical companies, which conducts clinical research trials on diag nostic assays; forensic identity testing used in criminal proceedings and parentage evaluation services, as well as testing services in reconstruction cases; allergy testing; and occupational testing for the detection of drug and alcohol abuse. Its customers include independent physicians and physician groups, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. The company operates a network of 51 primary laboratories and approximately 1,700 patient service centers. In addition, it delivers a co-branded electronic health records Lite solution for physician practices. The company works with university, hospital, and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlingto n, North Carolina.

Advisors’ Opinion:

  • [By Stephan Byrd]

    A number of brokerages recently weighed in on LH. Zacks Investment Research lowered Laboratory Corp. of America from a “hold” rating to a “sell” rating in a research report on Tuesday, January 8th. ValuEngine upgraded Laboratory Corp. of America from a “sell” rating to a “hold” rating in a research report on Monday. Barclays reduced their price objective on Laboratory Corp. of America from $205.00 to $165.00 and set an “overweight” rating on the stock in a research report on Monday, December 3rd. Credit Suisse Group boosted their price objective on Laboratory Corp. of America from $160.00 to $164.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 27th. Finally, Canaccord Genuity restated a “hold” rating and set a $155.00 price objective (down previously from $162.00) on shares of Laboratory Corp. of America in a research report on Sunday, December 2nd. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $176.07.

    WARNING: “Laboratory Corp. of America Holdings (LH) Shares Sold by Mirae Asset Global Investments Co. Ltd.” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at

    Laboratory Corp. of America Company Profile

  • [By Motley Fool Transcribers]

    Laboratory Corp Of America Holdings  (NYSE:LH)Q4 2018 Earnings Conference CallFeb. 07, 2019, 9:00 a.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Ethan Ryder]

    Laboratory Corp. of America Holdings (NYSE:LH) has been assigned a consensus rating of “Buy” from the eighteen ratings firms that are currently covering the company, reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $196.64.

  • [By Garrett Baldwin]

    If you’re looking to get your share of a booming, global growth story, look no further than Laboratory Corp. of America Holdings  (NYSE: LH).

    The Burlington, North Carolina-based company operates the largest network of clinical laboratories in the world. Its U.S. network has 36 labs and processes 2.5 million lab tests every week.

Top Warren Buffett Stocks To Own Right Now: Summit Hotel Properties, Inc.(INN)

Summit Hotel Properties, Inc., a hotel investment company, engages in acquiring, owning, renovating, repositioning, and asset-managing and selling premium-branded limited-service and select-service hotels in the upscale and midscale without food and beverage segments of the United StatesÂ’ lodging industry. As of August 3, 2012, the company operated 74 hotels with a total of 7,586 guestrooms located in 20 states. Summit Hotel Properties, Inc. was founded in 2004 and is based in Sioux Falls, South Dakota.

Leave a Reply

Your email address will not be published.